The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.

The obesity market is driving pharma’s return on investment (ROI) upward, with the projected return rising to 5.9% overall in 2024, but only reaching 3.8% if GLP-1 assets are excluded. At the same ...

A simple, freely available analysis tool and hardware for analyzing fruit flies allows opportunities for researchers in ...

“Brigaid is a company that hires professional chefs to work in school kitchens. We get to work with real ingredients and ...

In the fast-moving world of robotics we line up the most likely movers and makers vying to control the automated future ...

ArisGlobal announced a powerful new LifeSphere NavaX capability designed to redefine how life sciences organizations extract real-time, actionable intelligence from complex and fragmented data. By ...

Updates and the latest news as Elon Musk visits the Pentagon to discuss China and Trump and Pete Hegseth deliver remarks from ...

This study presents a valuable open-source and cost-effective method for automating the quantification of male aggression and courtship in Drosophila melanogaster. The work as presented provides solid ...